Antisense compounds, compositions and methods are provided for modulating the expression of SRC-1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding SRC-1. Methods of using these compounds for modulation of SRC-1 expression and for treatment of diseases associated with expression of SRC-1 are provided.
申请公布号
WO0244325(A2)
申请公布日期
2002.06.06
申请号
WO2001US44179
申请日期
2001.11.26
申请人
ISIS PHARMACEUTICALS, INC.;BAYLOR COLLEGE OF MEDICINE;O'MALLEY, BURT, W.;BENNETT, C., FRANK;COWSERT, LEX, M.
发明人
O'MALLEY, BURT, W.;BENNETT, C., FRANK;COWSERT, LEX, M.